Thermo Fisher lowers full-year outlook as revenue falls in Q3

Thermo Fisher Scientific endured another challenging quarter marked by declining revenue, according to its latest earnings report released Wednesday morning.

During Q3, Thermo Fisher’s revenue slid 1% to $10.57 billion, with organic revenue down 3%. Additionally, the company’s COVID-19 testing revenue totaled a mere $50 million, though its core organic revenue growth was 1%.